Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
about
Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons.The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre.Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.A Bayesian meta-analysis on prevalence of hepatitis B virus infection among Chinese volunteer blood donorsScreening for hepatitis C in average and high-risk populations of Qatar using rapid point-of-care testingA comprehensive serological and supplemental evaluation of hepatitis B "seroyield" blood donors: A cross-sectional study from a tertiary healthcare center in India.Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China.Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa RegionLight based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyondSeven Years Trends in Prevalence of Transfusion-Transmissible Viral Infections in Yazd blood Transfusion OrganizationHistorical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.A comparison of methods for estimating the incidence of human immunodeficiency virus infection in repeat blood donors.High prevalence of HIV p24 antigen among HIV antibody negative prospective blood donors in Ile-Ife, Nigeria.Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Zimbabwe.Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives
P2860
Q33739934-66BC5302-9FBB-4122-A2B2-D4D828AD3E35Q33953427-0AF0802C-959E-4DFA-A1F1-D39A8302FE25Q34255407-287F3BEC-C332-4F04-A94A-CFFC74A152BCQ35043752-887710F4-A577-4B25-8911-58587EBB36A9Q35926098-59023C3C-0B64-4483-A20B-640F467E7F96Q36034889-E469C12F-0EE3-421E-BB70-E4D59F134811Q36187319-00C2BC3D-63F6-4102-9743-7D61F4713776Q36254138-3B42FB3A-D0E8-4082-A4A8-88B81DF8CCA4Q37318721-F613C182-A387-4B8C-AB00-DD9853CD5EF4Q37579277-520A4376-A3C8-47DE-AE7E-2547FA13510BQ38948620-83AC1007-44C8-4603-BA3D-DE25518BDA9CQ39137413-9D9EC200-BF24-4DCB-8835-36E43C4838EDQ39860142-0DAAE045-A5E2-424E-84ED-17BACB98042CQ40071178-83C17C45-0D5C-4BA6-9739-5477B1D9E62AQ58999805-DA43920C-D5AF-4D6D-AA52-63552E3C6744
P2860
Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@en
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@nl
type
label
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@en
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@nl
prefLabel
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@en
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@nl
P2093
P2860
P1433
P1476
Trends in prevalence, incidenc ...... id testing, 2004 through 2009.
@en
P2093
Ali AlHashimi
Laila Al Shaer
Mahera AbdulRahman
Thomas J John
P2860
P304
P356
10.1111/J.1537-2995.2012.03740.X
P577
2012-06-13T00:00:00Z